One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future
Authors
Keywords
-
Journal
Journal of Allergy and Clinical Immunology-In Practice
Volume 9, Issue 5, Pages 1791-1803
Publisher
Elsevier BV
Online
2021-05-07
DOI
10.1016/j.jaip.2020.12.067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Developments in Non-allergen-specific Therapy for the Treatment of Food Allergy
- (2020) Andrew Long et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Placebo effects in allergen immunotherapy – an EAACI Task Force Position Paper
- (2020) O Pfaar et al. ALLERGY
- Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement
- (2020) Ludger Klimek et al. ALLERGY
- Past, presence, and future of allergen immunotherapy vaccines
- (2020) Yulia Dorofeeva et al. ALLERGY
- Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial.
- (2020) Christopher Thompson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- EAACI Allergen Immunotherapy User's Guide
- (2020) Montserrat Alvaro‐Lozano et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic – an EAACI/ARIA Position Paper
- (2020) O Pfaar et al. ALLERGY
- Production of allergen-specific immunotherapeutic agents for the treatment of food allergy
- (2020) Jeppe Madura Larsen et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs
- (2020) Jacobo López-Abente et al. EUROPEAN RESPIRATORY JOURNAL
- Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial
- (2020) Søren Helbo Skaarup et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
- (2020) David M. Fleischer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Microneedle-Mediated Allergen-Specific Immunotherapy for the Treatment of Airway Allergy in Mice
- (2020) Akhilesh Kumar Shakya et al. MOLECULAR PHARMACEUTICS
- Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
- (2020) Heimo Breiteneder et al. ALLERGY
- Oral immunotherapy for peanut allergy: The pro argument
- (2020) R. Sharon Chinthrajah et al. World Allergy Organization Journal
- Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
- (2020) Francesco Menzella et al. Journal of Asthma and Allergy
- Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research
- (2020) Amy M. Scurlock et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy
- (2019) David M. Fleischer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modulation of CRT h2 expression on allergen‐specific T cells following peptide immunotherapy
- (2019) Christopher D. Rudulier et al. ALLERGY
- Recombinant allergens for immunotherapy
- (2019) Yury Zhernov et al. Current Opinion in Allergy and Clinical Immunology
- Biologicals in allergic diseases and asthma: Toward personalized medicine and precision health: Highlights of the 3rd EAACI Master Class on Biologicals, San Lorenzo de El Escorial, Madrid, 2019
- (2019) Oscar Palomares et al. ALLERGY
- Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs
- (2019) Cristina Benito‐Villalvilla et al. ALLERGY
- Perspectives in allergen immunotherapy: 2019 and beyond
- (2019) Oliver Pfaar et al. ALLERGY
- Highlights of Novel Vaccination Strategies in Allergen Immunotherapy
- (2019) Zsolt István Komlósi et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Perspectives in allergen immunotherapy: 2017 and beyond
- (2018) O. Pfaar et al. ALLERGY
- EAACI guidelines on allergen immunotherapy: Executive statement
- (2018) A. Muraro et al. ALLERGY
- Peptide and Recombinant Allergen Vaccines for Food Allergy
- (2018) Quindelyn S. Cook et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization
- (2018) Stefan Schülke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy
- (2018) Tamar Kinaciyan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
- (2018) Verena Niederberger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
- (2018) J. M. Orengo et al. Nature Communications
- Allergen immunotherapy as add-on to biologic agents
- (2018) Carlo Lombardi et al. Current Opinion in Allergy and Clinical Immunology
- Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison
- (2018) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab for treatment of food allergy
- (2018) Manuel Jorge Rial et al. Journal of Allergy and Clinical Immunology-In Practice
- Recent developments and highlights in allergen immunotherapy
- (2018) Oliver Pfaar et al. ALLERGY
- Intralymphatic Immunotherapy: Update and Unmet Needs
- (2018) Gabriela Senti et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response
- (2018) JM Zubeldia et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Investigational new drugs for allergic rhinitis
- (2017) Peter A. Ricketti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Omalizumab facilitates rapid oral desensitization for peanut allergy
- (2017) Andrew J. MacGinnitie et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adjuvants for allergy immunotherapeutics
- (2017) Carlos Gamazo et al. Human Vaccines & Immunotherapeutics
- T Cell Epitope Peptide Therapy for Allergic Diseases
- (2016) Robyn E. O’Hehir et al. CURRENT ALLERGY AND ASTHMA REPORTS
- New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs)
- (2016) Ludger Klimek et al. Expert Review of Clinical Immunology
- Allergen Immunotherapy
- (2016) Peter Socrates Creticos IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1
- (2016) Sofía Sirvent et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sublingual grass and ragweed immunotherapy: Clinical considerations—a PRACTALL consensus report
- (2016) James T. Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti–IL-4: A randomized controlled trial
- (2016) Adam M. Chaker et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
- (2016) Robert A. Wood et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis
- (2016) Maria Kristiansen et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
- (2016) Gerard D. Wright TRENDS IN MICROBIOLOGY
- Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
- (2016) Petra Zieglmayer et al. EBioMedicine
- CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study
- (2015) T. B. Casale et al. ALLERGY
- Letter to the Editor Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
- (2015) Iwona Stelmach et al. Archives of Medical Science
- Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy
- (2015) S. R. Prickett et al. CLINICAL AND EXPERIMENTAL ALLERGY
- International consensus on allergy immunotherapy
- (2015) Marek Jutel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
- (2015) Ludger Klimek et al. Clinical and Translational Allergy
- Aluminium in Allergies and Allergen immunotherapy
- (2015) Erika Jensen-Jarolim World Allergy Organization Journal
- The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases
- (2014) O. Palomares et al. ALLERGY
- Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber
- (2013) W. Meyer et al. ALLERGY
- A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
- (2013) Lynda C. Schneider et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen
- (2013) Piyush Patel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study
- (2012) L. Klimek et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Adjuvants for immunotherapy
- (2012) Oliver Pfaar et al. Current Opinion in Allergy and Clinical Immunology
- Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study
- (2012) Deepen Patel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adjuvants for allergy vaccines
- (2012) Philippe Moingeon Human Vaccines & Immunotherapeutics
- Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens
- (2011) R. Valenta et al. ALLERGY
- Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
- (2011) Lawrence M. DuBuske et al. ALLERGY AND ASTHMA PROCEEDINGS
- Allergen immunotherapy: 100 years on
- (2011) S. R. Durham CLINICAL AND EXPERIMENTAL ALLERGY
- Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
- (2011) L. Klimek et al. CLINICAL AND EXPERIMENTAL ALLERGY
- A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy
- (2011) Stefan Schülke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- One hundred years of allergen immunotherapy: Time to ring the changes
- (2011) Stephen R. Durham et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
- (2011) Hugh A. Sampson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy
- (2011) Margitta Worm et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy
- (2011) Kari C. Nadeau et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
- (2010) Marc Massanari et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Future forms of immunotherapy
- (2010) Thomas B. Casale et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
- (2009) G. Senti et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
- (2009) Gabriela Senti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TLRs and innate immunity
- (2008) B. A. Beutler BLOOD
- Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
- (2008) Gabrielle Pauli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
- (2008) G. Senti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started